Home > Cardiovascular Risk
    • FILTER YOUR SEARCH
    Content Type:

    • Cardiovascular Risk

    Cardiovascular Risk Content

    Atherosclerosis, Cardiovascular Disease, Cardiovascular Risk
    touchPANEL DISCUSSION
    Current and future management of hyperlipidaemia and atherosclerosis: From statins to combination therapy
    CME ACCREDITED Prof. Alberico Catapano, Dr Jacques Genest, Prof. Kausik Ray Watch Time: 36 mins Available in:

    Watch an expert panel discuss cholesterol-lowering regimens in the management of hyperlipidaemia and atherosclerosis.

    Learning objectives
    Learning Objectives
    • Recall the current standard of care for cholesterol-lowering therapy and the potential limitations of statin monotherapy
    • Discuss the clinical considerations which guide the choice of second-line or add-on therapy when statin monotherapy is ineffective or not tolerated
    • Summarize the most recent data on the effect of dual lipid-lowering therapy on hyperlipidaemia and the risk for atherosclerosis
    Hypertension, Cardiovascular Risk
    touchEXPERT OPINIONS
    Medical therapy for CTEPH: From biology to new treatment options
    CME ACCREDITED Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK) Watch Time: 30 mins

    Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities, including the evolving data supporting the use of oral therapy, the application of oral therapies in clinical practice and how the underlying biology impacts on treatment decisions. This activity is intended for pulmonologists, cardiologists, cardiopulmonary surgeons, rheumatologists and other HCPs involved in the care of patients with CTEPH globally.

    Learning objectives
    Learning Objectives
    • Describe the biological and pathophysiological mechanisms of CTEPH
    • Summarize the evolving data supporting the use of oral therapies
    • Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72